Formulary considerations for drugs used to prevent cytomegalovirus disease.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Volumn 60, Issue 23 Suppl 8, 2003, Pages

  Pescovitz, Mark D ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; IMMUNOGLOBULIN;

ANTIBIOTIC PROPHYLAXIS; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYTOMEGALIC INCLUSION BODY DISEASE; ECONOMICS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; ORGAN TRANSPLANTATION; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; VIROLOGY;

ADMINISTRATION, ORAL; ANTIBIOTIC PROPHYLAXIS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; FORMULARIES; HUMANS; IMMUNOGLOBULINS; IMMUNOSUPPRESSION; OPPORTUNISTIC INFECTIONS; ORGAN TRANSPLANTATION; RANDOMIZED CONTROLLED TRIALS;

EID: 1542750498     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.suppl_8.s17     Document Type: Review

References (20)